Get the Stockscreener App
98.04
1.62%
-1.61
After Hours:
98.63
0.59
+0.60%
Overview
News
Price History
Option Chain
Financials
Why GILD Down?
Discussions
Forecast
Stock Split
Dividend History
Gilead Sciences Inc Stock (GILD) Latest News
Gilead Sciences (NASDAQ:GILD) Hits New 1-Year HighWhat's Next? - MarketBeat
Gilead Sciences Target of Unusually Large Options Trading (NASDAQ:GILD) - MarketBeat
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by abrdn plc - MarketBeat
Columbus Macro LLC Purchases 9,004 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Lazari Capital Management Inc. Cuts Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
943,628 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Purchased by Jennison Associates LLC - MarketBeat
Will Gilead's twice-yearly injection dominate the HIV PrEP market? GSK doesn’t think so - FiercePharma
3 Top AI-Powered Biotech Stocks to Buy in February - The Motley Fool
Ahead of Gilead (GILD) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
Concord Asset Management LLC VA Increases Position in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Discovering a Breakthrough: Gilead’s Long-Standing Commitment to Helping Change the Course of HIV - Gilead Sciences
Is Gilead Sciences (GILD) the Best Wide Moat Stock to Invest In? - Insider Monkey
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Money Concepts Capital Corp - MarketBeat
Alpha Omega Wealth Management LLC Reduces Stake in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Gilead Sciences, Inc. (NASDAQ:GILD) CFO Andrew D. Dickinson Sells 142,180 Shares - MarketBeat
Pharma Supply Chain Decarbonization Consortium Signs 10-Year Clean Energy Deals for Haleon, GSK, Thermo Fisher, Gilead - ESG Today
Gilead Sciences (GILD) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Yahoo Finance
Deutsche Bank Adjusts Price Target on Gilead Sciences to $80 From $73 -February 04, 2025 at 09:18 am EST - Marketscreener.com
Cullinan Associates Inc. Trims Position in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Gilead Sciences (GILD) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
BTC Capital Management Inc. Sells 17,282 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Foster & Motley Inc. Grows Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Cibc World Market Inc. Sells 64,941 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Concord Wealth Partners Purchases 6,194 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Gilead: Strong Sales Growth Remains With Veklury And Beyond (NASDAQ:GILD) - Seeking Alpha
Gilead Sciences Stock: Is Wall Street Bullish or Bearish? - Nasdaq
Gilead Sciences' (GILD) Sector Perform Rating Reaffirmed at Royal Bank of Canada - MarketBeat
Marginal Zone Lymphoma Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC, Hutchison Med - Barchart
Gilead Sciences Stock: Is Wall Street Bullish Or Bearish? - Barchart
Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Milestone Asset Management LLC - MarketBeat
Valley National Advisers Inc. Sells 9,062 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by McAdam LLC - MarketBeat
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat
SteelPeak Wealth LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Clear Creek Financial Management LLC Acquires Shares of 12,702 Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Mediolanum International Funds Ltd Has $5.32 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Baader Bank Aktiengesellschaft Purchases 7,328 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by Synergy Asset Management LLC - MarketBeat
Abel Hall LLC Sells 2,728 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Truvada Lawsuit | Settlements for HIV Med Side Effects [2025] - Sokolove Law News & Blog
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Caprock Group LLC - MarketBeat
Forsta AP Fonden Sells 5,300 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Twelve Points Wealth Management LLC Acquires New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Union Bancaire Privee UBP SA Purchases Shares of 16,732 Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts - Benzinga
Manning & Napier Advisors LLC Has $30.13 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
Cognizant, Gilead Sciences extend partnership for genAI - Mobihealth News
Will Gilead (GILD) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Gilead Sciences, Inc. (GILD): AI Partnerships Enhancing Biopharmaceutical Advancements - Insider Monkey
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Matrix Asset Advisors Inc. NY - MarketBeat
Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch
Cognizant to Provide Gilead With AI-Driven Tools Under Expanded Partnership -January 30, 2025 at 09:12 am EST - Marketscreener.com
Cognizant Expands Partnership with Gilead - Contract Pharma
Cognizant expands AI services for Gilead Sciences - Investing.com
Cognizant and Gilead Expand Partnership to Drive Greater Value Through Advanced Technology Applications - PR Newswire
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b - GlobeNewswire
Game-Changing HIV Vaccine Trial Fully Enrolled: HOOKIPA's Path to Potential Cure - StockTitan
Hantz Financial Services Inc. Has $5.87 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):